These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 19258214

  • 21. Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection.
    Teichmann J, Stephan E, Discher T, Lange U, Federlin K, Stracke H, Friese G, Lohmeyer J, Bretzel RG.
    Metabolism; 2000 Sep; 49(9):1134-9. PubMed ID: 11016893
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Abnormalities in the bone mineral metabolism in HIV-infected patients.
    García Aparicio AM, Muñoz Fernández S, González J, Arribas JR, Peña JM, Vázquez JJ, Martínez ME, Coya J, Martín Mola E.
    Clin Rheumatol; 2006 Jul; 25(4):537-9. PubMed ID: 16208429
    [Abstract] [Full Text] [Related]

  • 26. Sex hormone status and bone metabolism in men with Crohn's disease.
    Robinson RJ, Iqbal SJ, Al-Azzawi F, Abrams K, Mayberry JF.
    Aliment Pharmacol Ther; 1998 Jan; 12(1):21-5. PubMed ID: 9692696
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL, Lai PSM, Tan ATB, Ponnampalavanar S.
    Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy.
    Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):191-7. PubMed ID: 16886959
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Gonadal status is an important determinant of bone density in acromegaly.
    Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP.
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):59-65. PubMed ID: 9509069
    [Abstract] [Full Text] [Related]

  • 37. High bone turnover but normal bone mineral density in women suffering from schizophrenia.
    Bergemann N, Parzer P, Mundt C, Auler B.
    Psychol Med; 2008 Aug; 38(8):1195-201. PubMed ID: 18366816
    [Abstract] [Full Text] [Related]

  • 38. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
    Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, Mannazzu M, Falchi A, Mura MS, Madeddu G.
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):39-48. PubMed ID: 15195003
    [Abstract] [Full Text] [Related]

  • 39. High prevalence of hypogonadism and associated impaired metabolic and bone mineral status in subfertile men.
    Bobjer J, Bogefors K, Isaksson S, Leijonhufvud I, Åkesson K, Giwercman YL, Giwercman A.
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):189-95. PubMed ID: 26857217
    [Abstract] [Full Text] [Related]

  • 40. Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy.
    Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Mannazzu M, Falchi A, Sanna D, Mura MS, Madeddu G.
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):290-301. PubMed ID: 18596668
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.